World Institute of Pain

For enhanced security, we now require 2 Factor Authentication (2FA) to log into WIP website accounts. If you are an existing user, you have until August 25th, 2025 to activate 2FA on your account. After that date, your account will be locked and you will have to contact us for access.

Meet Saluda Medical at the WIP Orlando Workshop 8-10 April

Saluda Medical Receives FDA Approval for the Evoke® Spinal Cord Stimulation System to Treat Chronic Intractable Pain.

Saluda Medical is a global company revolutionizing the field of neuromodulation with an emerging portfolio of therapies driven by advanced closed-loop technologies designed to treat debilitating neurological disorders. The company’s first product, the Evoke® System, is the only ECAP-controlled closed-loop spinal cord stimulation (SCS) system and is indicated as an aid in the management of chronic intractable pain of the trunk and/or limbs, including unilateral or bilateral pain associated with failed back surgery syndrome, intractable low back pain, and leg pain.

https://www.saludamedical.com/2022/03/08/saluda-medical-receives-fda-approval-for-the-evoke-spinal-cord-stimulation-system-to-treat-chronic-intractable-pain/

Meet Saluda Medical at the WIP Orlando Workshop 8-10 April.

More info: orlandowip2022.congressline.hu

#wip #WorldInstituteOfPain #fippexam #cipsexam #wiporlando2022 #closedloop #scs #neuromodulation #ecaps #scsrevolution #evoke #chronicpain

The World Institute of Pain® is exempt from federal income tax under section 501(a) of the Internal Revenue Code as an
organization described in section 501(c)(3).

Federal ID No. 95‐4579119